Trial intelligence / Profile preview

Effexor XR vs Prozac for Recurrent Major Depression (PREVENT)

NCT00046020Phase 4Completed

Sponsor
Pfizer
Start
Aug 2000
Primary completion
Oct 2005
Modality
Small Molecules
01

Overview

A Phase 4 trial of venlafaxine in major depressive disorder (MDD), sponsored by Pfizer. Started Aug 2000; status: completed.

02

Drugs

venlafaxine
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00046020.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00046020.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call